Caffeine and Cataract After Pars Plana Vitrectomy (NCT06358664) | Clinical Trial Compass
UnknownNot Applicable
Caffeine and Cataract After Pars Plana Vitrectomy
Austria74 participantsStarted 2024-04-01
Plain-language summary
Assessment of cataract development in patients with regular caffeine consumption and those without caffeine consumption after pars plana vitrectomy.
Who can participate
Age range18 Years – 105 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 18 or older
* Written informed consent
* No previous cataract surgery in the study eye
* Scheduled small gauge vitrectomy with intraoperative gas tamponade (SF6 or C3F8) due to retinal detachment or macular hole repair
* No regular caffeine consumption (drinking not more than one cup of a caffeine- containing beverage \[e.g. coffee, energy drinks\] at a maximum of two days per week during the past year)
Exclusion Criteria:
* Intake of systemic or topical corticosteroids within 3 months before study screening
* Increased risk for postoperative cataract development, for example due to ocular trauma in the history
* Severe cataract (LOCS III grading of any cataract form \>2) in the study eye at pre- study screening
* Scheduled phacovitrectomy in the study eye
* Participation in any clinical trial three month before study screening
* Ocular surgeries six month before study screening
What they're measuring
1
Significant cataract formation at year 1
Timeframe: 12 months
Trial details
NCT IDNCT06358664
SponsorVienna Institute for Research in Ocular Surgery